![IJMS | Free Full-Text | MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes | HTML IJMS | Free Full-Text | MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes | HTML](https://www.mdpi.com/ijms/ijms-21-04471/article_deploy/html/images/ijms-21-04471-ag.png)
IJMS | Free Full-Text | MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes | HTML
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
![Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism | Neuropsychopharmacology Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2014.13/MediaObjects/41386_2014_Article_BFnpp201413_Fig1_HTML.jpg)
Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism | Neuropsychopharmacology
![Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism | Neuropsychopharmacology Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpp.2014.13/MediaObjects/41386_2014_Article_BFnpp201413_Fig4_HTML.jpg)